Advertisement

Topics

Latest Biological Patent NewsRSS

11:32 EDT 25th March 2017 | BioPortfolio

UC Berkeley Receives CRISPR Patent in Europe

The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

SCA Wins US Supreme Court Victory in Patent Infringement Suit

STOCKHOLM, March 24, 2017 /PRNewswire/ -- SCA, a leading global hygiene company and the maker of TENA® incontinence products, won an important victory before the United States Supreme Court on March 21, 2017 in its seven-year patent infringement case against First Quality Products, Inc. (SCA Hygiene Products Aktiebolag v. First Quality Baby Products, LLC.).   In a 7-1 decisio...

MiMedx To Present At The 16th Annual Needham Healthcare Conference

MARIETTA, Ga., March 24, 2017 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine and biopharmaceutical company utilizing human placental tissue allografts and patent-protected processes to develop and market advanced products and therapies for multiple sectors of healthcare, announced today  that it will present at the Needham Healthcare Conference in New Yor...

Applied Food Sciences Issued Patent for Producing Guayusa Extract featuring Caffeine and Chlorogenic Acids

AUSTIN, Texas, March 24, 2017 /PRNewswire/ -- Applied Food Sciences, Inc. (AFS) is pleased to announce it is the exclusive owner of U.S. Patent #9345707, a process patent that covers the production of enriched natural guayusa, from a single source plant, containing antioxidants, amino acids and caffeine.  The purpose of this process patent is to create a highly water soluble energy ingre...

TB Alliance Sublicenses Promising Anti-tuberculosis Drug from the Medicines Patent Pool

NEW YORK and GENEVA, March 24, 2017 /PRNewswire/ -- Agreement announced on World Tuberculosis Day revitalizes efforts to develop sutezolid as effective response to infectious disease killer  On World Tuberculosis Day, TB Alliance and the Medicines Patent Pool (MPP) announced a licensing agreement for the clinical development of sutezolid, an antibiotic drug candidate which demonstrate...

Argentum Persists In Challenging The "Evergreening" Patent On UCB, Inc.'s VIMPAT

  Life Sciences Jobs   ...

Mount Tam Biotechnologies Announces That The Japan Patent Office Has Allowed A Key Patent For Lead Compound TAM-01

  Life Sciences Jobs   ...

Endonovo Files A New Patent Application On Method To Treat Tissues And Organs Using Its Non-Invasive Electroceutical Technology

  Life Sciences Jobs   ...

Argentum Persists in Challenging the "Evergreening" Patent on UCB's VIMPAT®

NEW YORK, March 23, 2017 /PRNewswire/ -- In addition to reaching settlements granting Argentum Pharmaceuticals LLC rights to market lower-cost generics of other patented drugs, Argentum continues to challenge the sole remaining patent covering UCB's VIMPAT® drug in the U.S. Patent & Trademark Office. Argentum's challenge of the VIMPAT® patent is consistent with Argentum's mission of seeking ...

Endonovo Therapeutics Files a New Patent Application on Method to Treat Tissues and Organs Using Its Non-Invasive Electroceutical Technology

LOS ANGELES, CA -- (Marketwired) -- 03/23/17 -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a developer of non-invasive electroceuticals for the treatment of vascular diseases and inflammatory conditions in tissues and organs, today announced that it has filed a non-provisional patent application with the United States Patent and Trademark Office (USPTO) covering a me...

Leonhardt's Launchpads Expands Patent Estate With Option To Exclusive License Agreement With Caltech

March 22nd, 2017 - Santa Monica, CA, Pasadena, CA, Salt Lake City, Utah.--(PRBUZZ)-- Leonhardt's Launchpads, a Santa Monica, California and Salt Lake City, Utah based innovation accelerator focused on organ regeneration and recovery technologies announced today that it has significantly expanded its patent portfolio. Leonhardt's Launchpads via this agreement obtained an option leading to an exclu...

Groundbreaking Invention Revolutionizes Treatment of Plantar Fasciitis

8 out of 10 people report improvement in foot pain and/or function with The Healing Sole. Baton Rouge, Louisiana (PRWEB) March 22, 2017 Dr. Meredith Warner, a war veteran and orthopedic surgeon in Baton Rouge, LA, has revolutionized the treatment of plantar fasciitis, which affects one-tenth of the US population. With her recent and groundbreaking invention, The Healing Sole, Warner has created a...

Pulmatrix secures EU patent for dry powder delivery tech

Pulmatrix Inc has extended its IP portfolio with a European patent for its particle-based drug delivery technology.

STAT Plus: Pharmalot, Pharmalittle: Sanofi and Regeneron battle Amgen over patents, again

Sanofi and Regeneron Pharmaceuticals filed a lawsuit seeking to preempt a possible patent challenge from Amgen over their upcoming atopic dermatitis drug.

A Graduated Approach to Intellectual Property

We have expanded our approach to filing and enforcing patents to reflect a country's economic maturity. SOURCE: GSK DESCRIPTION:In 2016, we expanded our existing approach to filing and enforcing patents to ensure we balance the need to protect our intellectual property with a country’s economic maturity. We will no longer file patents for medicines in least-developed countries (LDCs) and lo...

Biogen staves off patent challenge to blockbuster MS drug

The U.S. Patent Trial and Appeal Board upheld a key patent on Biogen's Tecfidera, upping the odds the biotech is able to extend patent protection on the drug. 

USPTO Grants Composition of Matter Patent to Achillion for Small...

Achillion Pharmaceuticals, Inc. today announced that the U.S. Patent and Trademark Office has issued the first U.S. Patent to Achillion resulting from its complement factor D research program. U.S. Patent No.

Biogen's Victory Over $4 Billion MS Patent Spat Makes Company an Even More Attractive M&A Target

  Life Sciences Jobs   ...

PharmaCyte Biotech Strengthens Protection of Cancer Therapy with Patent Filing

LAGUNA HILLS, Calif., March 22, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced that it has filed a provisional patent application with the United States Patent and Trademark Office (US...

USPTO Grants Composition Of Matter Patent To Achillion For Small Molecule Complement Alternative Pathway Factor D Inhibitors

  Life Sciences Jobs   ...

GILUPI Extends Its Patent Portfolio

  Life Sciences Jobs   ...

Sanofi, Regeneron launch preemptive patent strike against Amgen

Having already been dealt a loss over Praluent patent infringement, the companies look to head off any claims from Amgen tied to their eczema drug Dupixent.

Eagle Pharmaceuticals Announces Three New Patents Issued for Bendeka

Bendeka protected by 14 patents running from 2026 through 2033 Thirteen Orange Book listed patents Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) (“Eagle” or “the Company”) today announced that three additional patents have been issued related to Bendeka by the United States Patent and Trademark Office (USPTO). Patent numbers 9,579,397 and ...

Pulmatrix Receives European Patent for its Inhaled Drug Delivery Technology

LEXINGTON, Mass., March 21, 2017 /PRNewswire/ -- Pulmatrix, Inc. (NASDAQ: PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary diseases, today announced that it has received a key patent from the European Union. "This new patent shows our continued ability to obtain patents that protect our unique iSPERSE inhaled drug tec...

USPTO Grants Composition of Matter Patent to Achillion for Small Molecule Complement Alternative Pathway Factor D Inhibitors

NEW HAVEN, Conn., March 21, 2017 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today announced that the U.S. Patent and Trademark Office (USPTO) has issued the first U.S. Patent to Achillion resulting from its complement factor D research program. U.S. Patent No. 9,598,446 has been granted with claims to compositions of matter for compounds that inhibit complement factor D...

Quick Search
Advertisement
 

review and buy Biological Patent market research data and corporate reports here